Whereas the single-cell resolution of flow cytometry will remain critical in many applications, the ability to multiplex over 30 protein targets, as well as hundreds of mRNA analytes, from a single blood draw using the NanoString RNA:Protein panel offers tremendous advantages to researchers and clinicians looking to obtain actionable data and patients seeking to minimize medical visits.